Skip to content


Open Access

Influence of an Ironman triathlon on sister chromatid exchanges and high frequency cells

  • Stefanie Reichhold1Email author,
  • Marlies Meisel1,
  • Oliver Neubauer1 and
  • Karl-Heinz Wagner1
BMC Pharmacology20077(Suppl 2):A61

Published: 14 November 2007


Peripheral Blood LymphocyteEndurance ExerciseSister Chromatid ExchangeModerate ExerciseHigh Volume Exercise


Regular moderate exercise and its beneficial influence on health have already been well-investigated. However, information on high volume exercise which might lead to increased oxidative stress and DNA damage is still very limited. The purpose of the present study was to investigate the effect of an Ironman triathlon race (3.8 km swim, 180 km cycle, 42 km run) on genomic stability and a possible DNA damage.

Materials and methods

The sister chromatid exchange (SCE) assay is a cytogenic biomarker, which can be influenced by various factors such as oxidative stress that occurs during extreme endurance exercise. Within this study SCEs and high frequency cells (HFCs) were measured in peripheral blood lymphocytes of nine well trained male triathletes (age 38 ± 6 years; VO2 peak 55.59 ± 2.97 ml/kg/min; height 179.1 ± 4.19 cm; weight 76.3 ± 4.27 kg). Blood samples were collected 48 h before and 24 h post race.


The mean SCE frequency in the Ironman triathletes 2 days before the race was 6.55 ± 2.71 per metaphase, which was significantly higher than post race (5.69 ± 2.60 SCEs per metaphase, p < 0.05). Additionally the mean of HFCs significantly decreased from 11.06 ± 2.66 per metaphase before the race to 9.42 ± 3.74 per metaphase post race (p < 0.05).


The significant decrease of SCEs and HFCs after the Ironman triathlon race provides an indication of endogenous repair mechanisms or counterregulations, which seem to prevent DNA damages probably through releasing antioxidants.

Authors’ Affiliations

Department of Nutritional Sciences, University of Vienna, Austria


© Reichhold et al; licensee BioMed Central Ltd. 2007

This article is published under license to BioMed Central Ltd.